Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
11.09B | 11.07B | 11.32B | 11.11B | 10.74B | Gross Profit |
1.64B | 759.70M | 792.80M | 770.50M | 716.30M | EBIT |
333.90M | 305.90M | 287.70M | 257.20M | 221.50M | EBITDA |
472.00M | 440.60M | 437.30M | 460.60M | 371.00M | Net Income Common Stockholders |
214.80M | 182.00M | 201.10M | 223.90M | 157.10M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
609.10M | 687.20M | 636.40M | 673.70M | 680.80M | Total Assets |
5.85B | 5.47B | 5.88B | 5.35B | 5.12B | Total Debt |
839.80M | 958.20M | 1.01B | 587.10M | 565.60M | Net Debt |
230.70M | 271.00M | 376.20M | -86.60M | -94.20M | Total Liabilities |
3.97B | 3.73B | 4.05B | 3.46B | 3.32B | Stockholders Equity |
1.82B | 1.69B | 1.76B | 1.81B | 1.74B |
Cash Flow | Free Cash Flow | |||
321.30M | 340.80M | 237.00M | 338.20M | 289.60M | Operating Cash Flow |
362.90M | 393.10M | 321.90M | 393.20M | 325.30M | Investing Cash Flow |
-75.60M | -116.50M | -511.80M | -147.90M | -103.20M | Financing Cash Flow |
-364.20M | -185.20M | 180.70M | -239.50M | -113.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | CHF15.95B | 26.44 | 3.86% | 2.60% | 3.16% | ||
71 Outperform | $4.84B | 18.51 | 22.45% | 2.79% | 7.58% | 14.41% | |
70 Outperform | $6.53B | 19.86 | 11.24% | 2.52% | 7.28% | 7.39% | |
69 Neutral | CHF2.15B | 21.83 | 2.37% | -2.41% | 4.65% | ||
64 Neutral | $4.25B | 11.69 | 5.23% | 249.83% | 4.04% | -9.46% | |
62 Neutral | CHF4.03B | 18.66 | 3.81% | 0.25% | 18.00% |
DKSH has been certified as a Great Place to Work® in 15 key markets, highlighting its commitment to a high-performing corporate culture and employee empowerment. This recognition underscores DKSH’s cultural transformation and its focus on trust, collaboration, and inclusion, which have positively impacted employee satisfaction and workplace environment.
DKSH has announced the acquisition of Zircon-Swis Fine Foods Pte Ltd, a prominent food service distributor in Singapore, as part of its strategy to expand its food service segment in the Asia Pacific region. This acquisition is expected to enhance DKSH’s market presence in Singapore’s dynamic food service industry by leveraging Zircon-Swis’s established network and focus on quality, thereby delivering long-term value and expanding capabilities in the region.
DKSH has partnered with Klimate to procure carbon dioxide removal credits as part of its commitment to achieving net-zero operations. The collaboration involves two projects: direct air capture in Kenya and biochar production in Thailand, which also supports local communities by providing sustainable income and improving air quality. This initiative aligns with DKSH’s broader sustainability efforts, which include optimizing transport routes, increasing energy efficiency, and expanding the use of electric and hybrid vehicles. The partnership highlights DKSH’s proactive approach to climate action and its support for the development of the carbon dioxide removal market.
DKSH has been awarded the EcoVadis Gold Medal for the third consecutive year, placing it among the top 5% of companies globally in terms of sustainability. This recognition highlights DKSH’s commitment to responsible business practices, particularly in labor and human rights, environment, ethics, and sustainable procurement. The company plans to set emissions reduction targets and expand its ISO certification programs, reinforcing its dedication to sustainability and positive local impact.
DKSH held its 92nd Annual General Meeting where shareholders approved all motions, including the reelection of Marco Gadola as Chairman and the appointment of Suwannee Ratthayabandith as a new Board member. A dividend increase of 4.4% was also authorized, reflecting DKSH’s commitment to its progressive dividend policy. The meeting underscored DKSH’s continued growth and strategic focus on the Asia Pacific region, highlighting its strong operational performance and commitment to sustainability. The approval of financial statements, compensation reports, and the reelection of auditors further solidified DKSH’s stable governance and strategic direction.
DKSH has signed an agreement to acquire Molecular Diagnostics Korea Inc. (MDxK), a prominent player in the South Korean life-science market, to strengthen its position in the molecular diagnostics sector. This acquisition is expected to enhance DKSH’s scientific solutions business in Asia, leveraging MDxK’s expertise and existing client relationships to meet the rising demand for advanced scientific solutions in South Korea.
DKSH Technology has announced the acquisition of Taqkey Science and Quantum Biotech, two Taiwanese companies specializing in the distribution of life science reagents and consumables. This strategic move is aimed at strengthening DKSH’s position as a leading scientific solutions provider in the Asia-Pacific region. The acquisition is expected to enhance DKSH’s regional presence and leverage Taqkey’s established client relationships, benefiting stakeholders and employees by expanding business opportunities and operational synergies.